Contract SPE2D323F178B
Hikma Pharmaceuticals USA Inc. · Department Of Defense · August 30, 2023
Hikma Pharmaceuticals USA Inc. was awarded a federal contract by Department Of Defense (Defense Logistics Agency) on August 30, 2023 for $951 of work in medicinal and botanical manufacturing. Performance is in Berkeley Heights, NJ. This is a task or delivery order issued under parent IDIQ SPE2D020D0006. It uses firm fixed-price contract pricing.
Contract details
- PIID
- SPE2D323F178B
- Parent IDIQ
- SPE2D020D0006
- Award type
- Delivery Order
- Pricing
- Firm Fixed Price
- Competition
- Full And Open Competition
- NAICS
- 325411 · Medicinal And Botanical Manufacturing
- Product / service
- Drugs And Biologicals
- Place of performance
- Berkeley Heights, NJ
- First action
- August 30, 2023
Description
4561991643!NALOXONE 2 MG/2 ML SYRINGE 2ML
Modification timeline
-
August 30, 2023Base award$951
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Amerisourcebergen Drug Corp | Department Of Defense | January 1, 2026 | $232 |
| Amerisourcebergen Drug Corp | Department Of Defense | January 1, 2026 | $13.1K |
| Amerisourcebergen Drug Corp | Department Of Defense | January 1, 2026 | $1.9K |
| Amerisourcebergen Drug Corp | Department Of Defense | January 1, 2026 | $220.9K |
| Amerisourcebergen Drug Corp | Department Of Defense | January 1, 2026 | $135 |
| Amerisourcebergen Drug Corp | Department Of Defense | January 1, 2026 | $39.8K |
Top contractors in NAICS 325411
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Mckesson Corporation | 372,977 | $24.02B |
| 2 | Amerisourcebergen Drug Corp | 1,414,856 | $18.32B |
| 3 | Glaxosmithkline, Llc | 44 | $5.42B |
| 4 | Merck Sharp & Dohme Llc | 3 | $1.50B |
| 5 | Novartis Vaccines And Diagnostics, Inc. | 132 | $1.07B |
| 6 | Sanofi Vaccines Us Inc. | 57 | $650.53M |
| 7 | Cardinal Health, Inc. | 42,916 | $603.29M |
| 8 | Dms Pharmaceutical Group Inc | 113,930 | $547.06M |
| 9 | Cardinal Health 100, Inc | 7,655 | $486.24M |
| 10 | Glaxosmithkline Holdings (Americas) Inc. | 72 | $280.01M |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract SPE2D323F178B?
Contract SPE2D323F178B is a federal contract awarded to Hikma Pharmaceuticals USA Inc. by Department Of Defense on August 30, 2023 for $951 of work classified under MEDICINAL AND BOTANICAL MANUFACTURING. It has been modified 0 times since the base award.
Who won contract SPE2D323F178B?
Hikma Pharmaceuticals USA Inc. won contract SPE2D323F178B from Department Of Defense.
How much is contract SPE2D323F178B worth?
Contract SPE2D323F178B has obligated $951 to date.